EQUITY RESEARCH MEMO

Klocke Group

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)65/100

Klocke Group is a leading contract manufacturing and packaging organization in Europe, specializing in solid dosage forms such as tablets, capsules, and sachets. Founded in 1990 and headquartered in Hamburg, Germany, the company provides end-to-end services for pharmaceutical and nutraceutical clients, including development, production, and blister packaging. With a strong reputation for quality and reliability, Klocke has expanded its capacity to meet growing demand for outsourced manufacturing, particularly from mid-sized and specialty pharma companies. The group benefits from the broader trend of pharmaceutical outsourcing and the increasing complexity of oral solid dose formulations. While the company is private and does not disclose financial details, its long-standing presence and client base suggest a stable revenue stream and moderate growth prospects.

Upcoming Catalysts (preview)

  • H2 2026Capacity expansion for high-potency active ingredients (HPAPIs)70% success
  • H1 2027New long-term contract with a top-10 pharma company50% success
  • TBDIndustry tailwinds from increased outsourcing by pharma80% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)